HETEROARYL DERIVATIVES AS ALPHA7 NACHR MODULATORS

Disclosed is a compound of formula (I), wherein Z, m and R1 -R6 are as described herein, as a modulator of nicotinic acetylcholine receptors particularly the α7 subtype, in a subject in need thereof, as well as analogues, prodrugs, isotopically substituted analogs, metabolites, pharmaceutically acce...

Full description

Saved in:
Bibliographic Details
Main Authors KURHADE, SANJAY, PRALHAD, PALLE, VENKATA, P, KAMBOJ, RAJENDER, KUMAR, SINHA, NEELIMA, HAJARE, ANIL, KASHIRAM, TILEKAR, AJAY, RAMCHANDRA, SACHCHIDANAND, SACHCHIDANAND, JANA, GOURHARI, KARCHE, NAVNATH, POPAT
Format Patent
LanguageEnglish
Published 30.09.2013
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a compound of formula (I), wherein Z, m and R1 -R6 are as described herein, as a modulator of nicotinic acetylcholine receptors particularly the α7 subtype, in a subject in need thereof, as well as analogues, prodrugs, isotopically substituted analogs, metabolites, pharmaceutically acceptable salts, polymorphs, solvates, isomers, clathrates, and co-crystal thereofs, for use either alone or in combinations with suitable other medicaments, and pharmaceutical compositions containing such compounds and analogues. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and therapy of disorders such as Alzheimer's disease, mild cognitive impairment, senile dementia, and the like.
Bibliography:Application Number: SG20130059431